Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |